ClinicalTrials.gg
CompletedNCT01300169OWLUpdated May 31, 2017

Operation Worth Living Project With Suicidal Soldiers at Ft. Stewart

An interventional study of The Collaborative Assessment and Management of Suicidality and Enhanced Care as Usual in Suicidal Ideation Active and Suicidal and Self-injurious Behavior, sponsored by The Catholic University of America. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-05-31.

Sponsored by The Catholic University of America · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This is a randomized controlled trial comparing the use of new clinical intervention (the "Collaborative Assessment and Management of Suicidality--CAMS") versus enhanced care as usual for suicidal Soldiers who are seen at outpatient mental health clinics at Ft. Stewart GA.

Read the detailed description

This is a randomized controlled clinical trial of 148 suicidal active-duty US Army Soldiers. Participants were randomized to on-site providers who were trained in the Collaborative Assessment and Management of Suicidality (CAMS) vs. providers doing their own routine care--referred to as Enhanced Care as Usual (E-CAU) within an outpatient military treatment center. The CAMS Rating Scale (CRS) was used to reliably verify fidelity between treatment conditions and the adherence by CAMS providers to the model. Participants received informed consent to be randomly assigned to treatment arm and were ask to complete study assessments at baseline, 3 months, 6 months, and 12 months after the start of treatment. Recruitment is complete and all study assessments were completed as of March 2016. The study is in a second year of no cost extension; outcome data analyses and moderator analyses are currently underway to develop manuscripts for submission to peer-review scientific journals.

02

Conditions studied

  • Suicidal Ideation Active
  • Suicidal and Self-injurious Behavior

Keywords

  • Suicide
  • Assessment
  • Intervention
  • CAMS
03

In context

Self-Injurious Behavior

303 studies on the registry are indexed under Self-Injurious Behavior; 105 are open to participants now.

This study's enrollment of 150 is above the median of 70 across 254 interventional studies indexed under Self-Injurious Behavior.

Browse Self-Injurious Behavior studies →

Lead sponsor

The Catholic University of America is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Active duty Army personnel at FSGA
  • Significant suicidal ideation
  • Soldier is appropriate under FSGA policies
  • Consent at baseline and follow up
  • Consent to randomization and being digitally recorded

Exclusion criteria

Exclusion Criteria:

  • Significant psychosis, cognitive or physical impairment to not give consent
  • Judicially ordered treatments
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Double (Participant, Outcomes assessor)
Enrollment
150 participants (actual)

Study arms

  • Experimental
    CAMS--Collaborative Driver-Treatment

    The Collaborative Assessment and Management of Suicidality (CAMS) is a suicide-specific clinical intervention that targets and treats patient-defined suicidal "drivers" over the course of clinical care.

    Behavioral: The Collaborative Assessment and Management of Suicidality

  • Active comparator
    Enhanced Care as Usual--E-CAU

    This control group treatment will reflect current clinical practices for treating suicidal soldiers in the research site setting. These are providers were on site clinicians who provided care according to their usual and customary practices for working with suicidal risk within outpatient care.

    Behavioral: Enhanced Care as Usual

Interventions

  • BehavioralThe Collaborative Assessment and Management of Suicidality

    Intensive outpatient, suicide-focused, psychotherapy designed to target and treat the "drivers" of suicidal ideation and behaviors.

  • BehavioralEnhanced Care as Usual

    This is just standard outpatient mental health care that is routinely provided in the study site outpatient clinic

06

What researchers measure

Primary outcomes

  1. Scale for Suicidal Ideation

    Industry standard for self-report suicidal ideation

    Time frame: Baseline, post-treatment, 1, 3, 6, 12 months

Secondary outcomes

  1. Overall symptom distress

    Outcome Questionnaire-45

    Time frame: Baseline, post treatment, 1, 3, 6, 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Corona CD, Gutierrez PM, Wagner BM, Jobes DA. The psychometric properties of the Collaborative Assessment and Management of Suicidality rating scale. J Clin Psychol. 2019 Jan;75(1):190-201. doi: 10.1002/jclp.22699. Epub 2018 Oct 6. PubMed 30291761 ↗
  • Jobes DA, Comtois KA, Gutierrez PM, Brenner LA, Huh D, Chalker SA, Ruhe G, Kerbrat AH, Atkins DC, Jennings K, Crumlish J, Corona CD, Connor SO, Hendricks KE, Schembari B, Singer B, Crow B. A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality versus Enhanced Care as Usual With Suicidal Soldiers. Psychiatry. 2017 Winter;80(4):339-356. doi: 10.1080/00332747.2017.1354607. PubMed 29466107 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2011, a primary completion of Mar 2017 and a completion of Mar 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2011
First posted
Feb 21, 2011
Start
Mar 2011
Primary completionActual
Mar 15, 2017
CompletionActual
Mar 15, 2017
Last update
May 31, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01300169
Lead sponsor
The Catholic University of America
Responsible party
David A. Jobes, Ph.D. (Professor of Psychology, The Catholic University of America) — Principal investigator
First posted
Feb 21, 2011
Start date
Mar 2011
Primary completion
Mar 15, 2017
Completion
Mar 15, 2017
Last update
May 31, 2017

Study contacts

David A. Jobes, Ph.D.
principal investigator · The Catholic University of America

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion